Star Imaging and Path Lab Expands Diagnostic Capabilities and Secures CGHS Empanelment

1 min read     Updated on 11 Nov 2025, 01:54 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Star Imaging And Path Lab Limited has added new CT scan and 3 Tesla MRI facilities to its Vikaspuri center in New Delhi, expanding its diagnostic capabilities. The company has also secured empanelment under the Central Government Health Scheme (CGHS), allowing it to serve central government employees, PSU employees, and other eligible individuals. These developments are expected to broaden the company's patient base and strengthen its position in the diagnostic healthcare sector.

24395092

*this image is generated using AI for illustrative purposes only.

Star Imaging And Path Lab Limited (BSE: 544482) has announced significant developments that are set to enhance its diagnostic capabilities and expand its patient base. The company, which specializes in providing diagnostic and healthcare services, has made strategic moves to strengthen its position in the healthcare industry.

Advanced Imaging Facilities

Star Imaging and Path Lab has successfully added new, state-of-the-art diagnostic modalities to its existing center in Vikaspuri, New Delhi. The company has introduced:

  • CT scan facility
  • 3 Tesla MRI facility

These advanced imaging technologies are now fully operational, marking a significant upgrade to the company's diagnostic capabilities. The introduction of these high-resolution imaging services is expected to cater to a broader patient base and improve the quality of diagnostic services offered by the company.

CGHS Empanelment

In a move that could substantially increase its reach, Star Imaging and Path Lab has secured empanelment under the Central Government Health Scheme (CGHS). This development brings several advantages:

Aspect Details
Beneficiaries Central Government Employees, Public Sector Undertaking (PSU) Employees, Other eligible individuals
Expected Impact Broader patient base, Enhanced service reach
Target Segments Government and PSU sectors

The CGHS empanelment is anticipated to strengthen the company's presence and reputation in the diagnostic healthcare industry by allowing it to serve a significant number of government and PSU employees.

Strategic Implications

These developments align with Star Imaging and Path Lab's ongoing strategy to:

  1. Expand its service offerings
  2. Strengthen its technological infrastructure
  3. Enhance its market position in the diagnostic healthcare sector

By investing in advanced imaging technologies and securing government empanelment, the company is positioning itself for potential growth and improved service delivery in the competitive healthcare market.

As the healthcare sector continues to evolve, companies like Star Imaging and Path Lab are focusing on technological advancements and strategic partnerships to meet the growing demand for high-quality diagnostic services. These moves could potentially lead to improved patient care and a stronger foothold in the diagnostic healthcare industry.

Investors and stakeholders will likely be watching closely to see how these developments translate into operational and financial performance for Star Imaging and Path Lab Limited in the coming quarters.

Historical Stock Returns for Star Imaging And Path Lab

1 Day5 Days1 Month6 Months1 Year5 Years
+1.61%-8.93%-11.55%-9.56%-9.56%-9.56%
Star Imaging And Path Lab
View in Depthredirect
like17
dislike
Explore Other Articles
122.95
+1.95
(+1.61%)